MDM4 and liver cancer: Besides, the amplification and high-level expression of MDMX has been reported in subtypes of liver cancer, i.e., hepatoblastoma and fibrolamellar hepatocellular carcinoma, but the clinical relevance of these findings in liver cancer is not yet clear (72, 73).